Literature DB >> 21115854

Amifostine in the treatment of head and neck cancer: intravenous administration, subcutaneous administration, or none of the above.

Avraham Eisbruch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21115854     DOI： 10.1200/JCO.2010.31.5051

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  CD47 deficiency confers cell and tissue radioprotection by activation of autophagy.

Authors:  David R Soto-Pantoja; Thomas W Miller; Michael L Pendrak; William G DeGraff; Camille Sullivan; Lisa A Ridnour; Mones Abu-Asab; David A Wink; Maria Tsokos; David D Roberts
Journal:  Autophagy       Date:  2012-08-09       Impact factor: 16.016

Review 2.  Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis.

Authors:  Charles T Lee; Thomas J Galloway
Journal:  Curr Treat Options Oncol       Date:  2022-03-04

3.  Prophylactic administration of Amifostine protects vessel thickness in the setting of irradiated bone.

Authors:  Erin E Page; Sagar S Deshpande; Noah S Nelson; Peter A Felice; Alexis Donneys; Jose J Rodriguez; Samir S Deshpande; Steven R Buchman
Journal:  J Plast Reconstr Aesthet Surg       Date:  2014-08-30       Impact factor: 2.740

4.  Amifostine preserves osteocyte number and osteoid formation in fracture healing following radiotherapy.

Authors:  Alexis Donneys; Catherine N Tchanque-Fossuo; Jordan T Blough; Noah S Nelson; Sagar S Deshpande; Steven R Buchman
Journal:  J Oral Maxillofac Surg       Date:  2013-12-15       Impact factor: 1.895

5.  p53-based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study.

Authors:  Chul S Ha; Joel E Michalek; Richard Elledge; Kevin R Kelly; Suthakar Ganapathy; Hang Su; Carol A Jenkins; Athanassios Argiris; Ronan Swords; Tony Y Eng; Anand Karnad; Richard L Crownover; Gregory P Swanson; Martin Goros; Brad H Pollock; Zhi-Min Yuan
Journal:  Mol Oncol       Date:  2015-09-18       Impact factor: 6.603

6.  Localized Delivery of Amifostine Enhances Salivary Gland Radioprotection.

Authors:  J J Varghese; I L Schmale; D Mickelsen; M E Hansen; S D Newlands; D S W Benoit; V A Korshunov; C E Ovitt
Journal:  J Dent Res       Date:  2018-04-10       Impact factor: 6.116

Review 7.  Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.

Authors:  Vijay K Singh; Patricia L P Romaine; Thomas M Seed
Journal:  Health Phys       Date:  2015-06       Impact factor: 1.316

Review 8.  Radiation-Induced Oral Mucositis.

Authors:  Osama Muhammad Maria; Nicoletta Eliopoulos; Thierry Muanza
Journal:  Front Oncol       Date:  2017-05-22       Impact factor: 6.244

9.  Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio.

Authors:  Aron Popovtzer; Daniel Normolle; Francis P Worden; Mark E Prince; Douglas B Chepeha; Gregory T Wolf; Carol R Bradford; Theodore S Lawrence; Avraham Eisbruch
Journal:  Transl Oncol       Date:  2014-08       Impact factor: 4.243

Review 10.  A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis.

Authors:  Bryan Oronsky; Sharad Goyal; Michelle M Kim; Pedro Cabrales; Michelle Lybeck; Scott Caroen; Neil Oronsky; Erica Burbano; Corey Carter; Arnold Oronsky
Journal:  Transl Oncol       Date:  2018-04-23       Impact factor: 4.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.